跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 100/6 pressurised metered dose inhaler - TGA Drug Approval Details
Approvals
/
TGA
/
SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 100/6 pressurised metered dose inhaler
Approved
STANDARD
SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 100/6 pressurised metered dose inhaler
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4f4e638548a20917
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
4f4e638548a20917
Product Name
SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 100/6 pressurised metered dose inhaler
Artg Id
115552
Artg Name
SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 100/6 pressurised metered dose inhaler
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
2006-02-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/a103aadf447c4b10dae059993d4f14f7.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4f4e638548a20917
Type
Standard
Back to TGA Approvals